Skip to main content
#
Drug Injury Lawyer 24/7

FDA Drug & Medical Device Recall News & Comments 
Wednesday, October 21 2009

American Regent Voluntarily Recalls All Lots of Ketorolac
Tromethamine Injection, USP 30 mg/mL; 1mL and 2mL Single Dose Vials

FOR IMMEDIATE RELEASE - October 20, 2009 - Shirley, NY - American Regent conducts nationwide voluntary recall of ALL lots of its Ketorolac Tromethamine Injection, USP 30 mg/mL:

 NDC# 0517-0801-25 30 mg/mL 1mL Single Dose Vial

 NDC# 0517-0902-25 30mg/mL 2mL Single Dose Vial (60mg/2mL) 

This voluntary recall is due to the potential that particulate matter in conjunction with crystallization may be present in the product. This recall does not include other concentrations of AMERICAN REGENT Ketorolac Tromethamine Injection, USP. American Regent is undertaking this recall in consideration of the potential for safety issues if the product is administered to patients, including obstruction of blood vessels which can induce pulmonary emboli or thrombosis, activate platelets and/or neutrophils to induce anaphylactic reactions. Other adverse effects associated with the injection of particulate matter include foreign body granulomas, and local irritation at the injection site. 

The product was distributed to wholesalers and distributors nationwide and to one account in Abu Dhabi.

Hospitals, surgi-centers, clinics and other healthcare facilities should not use any AMERICAN REGENT Ketorolac Tromethamine Injection, USP Injection 30 mg/mL for patient care and should immediately quarantine any product for return. 

"Patient safety is our primary concern, and we are committed to taking the necessary steps to protect patients from any potential safety risks," said Mary Jane Helenek, President and CEO of American Regent. 

On Friday, October 16, 2009, American Regent voluntarily recalled ALL unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL due to the presence of particulate matter in conjunction with crystallization. This recall does not affect the other strength of Ketorolac Tromethamine Injection, USP, 15mg/mL, 1 mL Single Dose Vial, NDC # 0517-0601-25. 

While American Regent continues to investigate this issue, the company is taking precautionary action and initiated this voluntary recall. American Regent has informed the FDA of its actions and is maintaining ongoing discussions with the Agency. 

As is standard practice, and as stated in the Ketorolac Tromethamine Injection Product Package Insert, "Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit"

American Regent will credit accounts for all returned Ketorolac Tromethamine Injection, USP product. Those with questions about the return process, please call our Customer Service Department at 1-800-645-1706: Monday thru Friday from 8:30 AM to 7:00 PM ET. 

Hospitals, surgi-centers, clinics and healthcare providers, or patients with other questions may contact the Professional Services Department at 631-924-4000. 

Any adverse reactions experienced with the use of this product, and/or quality problems should be reported to American Regent, Inc. via email at PV@luitpold.com, by fax to 610-650-7781 or 610-650-0170 or by phone at 1-800-734-9236. Adverse reactions may also be reported to FDA's MedWatch Adverse Event Reporting program online, by phone [1-800-FDA-1088], or by returning the postage paid FDA form 3500, by mail to [MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787] or via fax [1-800-FDA-0178]. 

Ketorolac Tromethamine Injection, USP is manufactured by Luitpold Pharmaceuticals, Inc. and is distributed by American Regent, Inc. (Shirley, NY).

Ketorolac Tromethamine Injection Injury Lawsuit

If you or a loved one have have been injured had serious injury as a result of a recalled or defective Ketorolac Tromethamine Injection, then call us to discuss your legal rights to monetary compensation for your injuries or the death of a loved one. The Willis Law Firm has represented thousands of clients across the United States in defective and recalled medical devices, recalled drugs and other product liability claims. Mr. Willis is a Board Certified Trial Lawyer with 25+ years of legal experience. Call us at 1-800-883-9858 or fill out our online case form.

 

Posted by: DW AT 03:29 pm   |  Permalink   |  Email
Willis Law Firm - Houston, Texas Drug Injury Lawyer and Attorney Free Lawsuit & Class Action Lawsuit Lawyer

 

LEGAL ADVERTISING

THIS WEBSITE IS NOT A MEDICAL SITE

This is an Attorney / Lawyer Advertising Website. It is not a medical information, medical dictionary, medical advice or medical help site. Talk to you own treating Doctor about any questions or concerns that you have concerning any medicine, drug, medical device or treatment plan. Do not rely on any information on this site to alter, stop or change any medication or treatment plan by your prescribing or treating Doctor. Many of the drugs and devices listed here on this site have published risk and warnings associated with their use and have not been recalled. This website is not in anyway connected with any drug company or the FDA.Check with your Doctor, Pharmacy and/or the FDA as to any concerns as to their use, recall status and safety. See http://www.fda.gov/ for the latest information.

Principal Office -Willis Law Firm 5005 Riverway Drive, Suite #160 Houston, Texas 77056

____________

.

.

.

.

.